- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid management in patients with chronic kidney disease
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 14, Issue 12, Pages 727-749
Publisher
Springer Nature
Online
2018-10-25
DOI
10.1038/s41581-018-0072-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Therapeutic Approaches for Familial Hypercholesterolemia
- (2018) Ezim Ajufo et al. Annual Review of Medicine
- CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease PatientsHighlights
- (2018) Andreas Gille et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient (LDLR+/−andLDLR−/−) Yucatan Miniature PigsHighlights
- (2018) Amy C. Burke et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Pre-Specified Secondary End Points in ORION 1
- (2018) Kausik K. Ray et al. CIRCULATION
- Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting
- (2018) BinBin Zheng-Lin et al. DRUGS
- Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease
- (2018) Julio A Lamprea-Montealegre et al. HEART
- Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors
- (2018) Charles L. Bisgaier et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The ODYSSEY Outcomes trial: Clinical implications and exploration of the limits of what can be achieved through lipid lowering
- (2018) Kevin C. Maki Journal of Clinical Lipidology
- The role of lipoprotein (a) in chronic kidney disease
- (2018) Jemma C. Hopewell et al. JOURNAL OF LIPID RESEARCH
- HDL in CKD—The Devil Is in the Detail
- (2018) Florian Kronenberg JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
- (2018) Benjamin C. Storey et al. KIDNEY INTERNATIONAL
- Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease
- (2018) Peter P. Toth et al. KIDNEY INTERNATIONAL
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
- (2018) Theingi Aung et al. JAMA Cardiology
- Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
- (2018) Stephen J. Nicholls et al. CLINICAL CARDIOLOGY
- Apolipoprotein A-I Infusion Therapies for Coronary Disease
- (2018) Daniel J. Rader JAMA Cardiology
- Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials
- (2017) Konstantinos C Koskinas et al. EUROPEAN HEART JOURNAL
- New perspectives on CKD-induced dyslipidemia
- (2017) Marcelino Bermúdez-López et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
- (2017) Iryna Schlackow et al. HEART
- Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism
- (2017) Hua Chen et al. JOURNAL OF PROTEOME RESEARCH
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
- (2017) Raimund Pechlaner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2017) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
- (2017) Shipra Agrawal et al. Nature Reviews Nephrology
- Reducing the costs of chronic kidney disease while delivering quality health care: a call to action
- (2017) Raymond Vanholder et al. Nature Reviews Nephrology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligonucleotide Therapeutics — A New Class of Cholesterol-Lowering Drugs
- (2017) Anastasia Khvorova NEW ENGLAND JOURNAL OF MEDICINE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients
- (2017) Gunnar H. Heine et al. SEMINARS IN DIALYSIS
- Protein Nutrition and Malnutrition in CKD and ESRD
- (2017) Yan Zha et al. Nutrients
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
- (2017) Stephen Zewinger et al. Lancet Diabetes & Endocrinology
- Trials and Tribulations of CETP Inhibitors
- (2017) Alan R. Tall et al. CIRCULATION RESEARCH
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
- (2017) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
- (2016) Marc S. Sabatine et al. AMERICAN HEART JOURNAL
- Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
- (2016) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
- (2016) Xiaole Su et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
- (2016) Finnian R. Mc Causland et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD
- (2016) Talar Markossian et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
- (2016) Borislava Mihaylova et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial
- (2016) Michel Farnier et al. ATHEROSCLEROSIS
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. ATHEROSCLEROSIS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. ATHEROSCLEROSIS
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2016) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated HypercholesterolemiaClinical Perspective
- (2016) Mary E. Haas et al. CIRCULATION
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics
- (2016) Josep Julve et al. CLINICA CHIMICA ACTA
- Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
- (2016) Shravanthi R. Gandra et al. CLINICAL CARDIOLOGY
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- The effects of the Danish saturated fat tax on food and nutrient intake and modelled health outcomes: an econometric and comparative risk assessment evaluation
- (2016) S Smed et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
- (2016) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development of Antisense Drugs for Dyslipidemia
- (2016) Tsuyoshi Yamamoto et al. Journal of Atherosclerosis and Thrombosis
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance
- (2016) Paul D. Thompson et al. Journal of Clinical Lipidology
- Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients
- (2016) Evan Stein et al. Journal of Clinical Lipidology
- Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results
- (2016) Xiaohong Yang et al. JOURNAL OF LIPID RESEARCH
- Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences
- (2016) Nosratola D. Vaziri KIDNEY INTERNATIONAL
- No small task: therapeutic targeting of Lp(a) for cardiovascular disease
- (2016) Mark W Feinberg LANCET
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease
- (2016) Dorota Drożdż et al. Oxidative Medicine and Cellular Longevity
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
- (2016) Wijtske Annema et al. Translational Research
- Participation of the elderly, women, and minorities in pivotal trials supporting 2011–2013 U.S. Food and Drug Administration approvals
- (2016) Nicholas S. Downing et al. Trials
- Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
- (2016) Stephen L. Pinkosky et al. Nature Communications
- Statins evidence: when answers also raise questions
- (2016) Harlan M Krumholz BMJ-British Medical Journal
- Statins evidence: when answers also raise questions
- (2016) Harlan M Krumholz BMJ-British Medical Journal
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population
- (2016) Michael Thompson et al. Journal of Clinical Medicine
- PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
- (2016) Kyrill S. Rogacev et al. PLoS One
- Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study
- (2015) Dean J. Kereiakes et al. AMERICAN HEART JOURNAL
- Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
- (2015) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cholesterol Metabolism in CKD
- (2015) Allison B. Reiss et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD
- (2015) Mark J. Sarnak et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Association of Serum Lipids with Outcomes in Hispanic Hemodialysis Patients of the West versus East Coasts of the United States
- (2015) Hamid Moradi et al. AMERICAN JOURNAL OF NEPHROLOGY
- Update on Inflammation in Chronic Kidney Disease
- (2015) Oleh M. Akchurin et al. BLOOD PURIFICATION
- Clinical trials in children
- (2015) Pathma D. Joseph et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis
- (2015) R. W. Major et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial
- (2015) Christopher P. Cannon et al. EUROPEAN HEART JOURNAL
- Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial
- (2015) Harold Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
- (2015) Paul D. Thompson et al. Journal of Clinical Lipidology
- Efficacy and safety of mipomersen in treatment of dyslipidemia: A meta-analysis of randomized controlled trials
- (2015) Raju Panta et al. Journal of Clinical Lipidology
- Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects
- (2015) Charles D. Meyers et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Current therapies for lowering lipoprotein (a)
- (2015) Julian C. van Capelleveen et al. JOURNAL OF LIPID RESEARCH
- Cardiovascular risk assessment in kidney transplantation
- (2015) Allyson Hart et al. KIDNEY INTERNATIONAL
- Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates
- (2015) Markus P. Schneider et al. KIDNEY INTERNATIONAL
- Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) G Kees Hovingh et al. LANCET
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
- (2015) Charles Daniel Meyers et al. Lipids in Health and Disease
- HDL abnormalities in nephrotic syndrome and chronic kidney disease
- (2015) Nosratola D. Vaziri Nature Reviews Nephrology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy
- (2015) Luca De Nicola et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Efficacy and Safety of Alirocumab as Add-on Therapy in High-Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
- (2015) Jennifer G. Robinson et al. CLINICAL CARDIOLOGY
- Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance
- (2015) Andrea R. Zammit et al. PLoS One
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- (2014) Gregory G. Schwartz et al. AMERICAN HEART JOURNAL
- Reduction of Low-Density Lipoprotein Cholesterol by Monoclonal Antibody Inhibition of PCSK9
- (2014) Evan A. Stein et al. Annual Review of Medicine
- Efficacy and Safety of ETC-1002, a Novel Investigational Low-Density Lipoprotein-Cholesterol–Lowering Therapy for the Treatment of Patients With Hypercholesterolemia and Type 2 Diabetes Mellitus
- (2014) Maria J. Gutierrez et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
- (2014) Anne Langsted et al. ATHEROSCLEROSIS
- Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
- (2014) Helen M Colhoun et al. BMC Cardiovascular Disorders
- Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
- (2014) John J. P. Kastelein et al. CARDIOVASCULAR DRUGS AND THERAPY
- Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
- (2014) J.-C. Tardif et al. EUROPEAN HEART JOURNAL
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
- (2014) HEART
- Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients
- (2014) Carlo M. Barbagallo et al. Hemodialysis International
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
- (2014) Jennifer G. Robinson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
- (2014) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease
- (2014) Ana Reis et al. JOURNAL OF LIPID RESEARCH
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
- (2014) Erik Stroes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-PCSK9 Monotherapy for Hypercholesterolemia
- (2014) Michael J. Koren et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction
- (2014) S. Zewinger et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
- (2014) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients
- (2014) G. Silbernagel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
- (2014) R. Haynes et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Diabetic dyslipidemia
- (2014) Liya Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease
- (2014) Suetonia C Palmer et al. NEPHROLOGY
- Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
- (2014) H. Moradi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients
- (2014) Darren Green et al. NEPHRON CLINICAL PRACTICE
- A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- (2014) Dirk J. Blom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia
- (2014) Howard S. Weintraub POSTGRADUATE MEDICINE
- Defining the Natural History of Uremic Cardiomyopathy in Chronic Kidney Disease
- (2014) Nicola C. Edwards et al. JACC-Cardiovascular Imaging
- Monitoring Cholesterol Levels: Measurement Error or True Change?
- (2013) Paul P. Glasziou et al. ANNALS OF INTERNAL MEDICINE
- Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease
- (2013) Crystal M. Smith-Spangler ANNALS OF INTERNAL MEDICINE
- Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs
- (2013) David M. Eddy et al. ANNALS OF INTERNAL MEDICINE
- Chronic Kidney Disease, Plasma Lipoproteins, and Coronary Artery Calcium Incidence
- (2013) Julio A. Lamprea-Montealegre et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice
- (2013) Claudine Tardy et al. ATHEROSCLEROSIS
- Reasons for the Lack of Salutary Effects of Cholesterol-Lowering Interventions in End-Stage Renal Disease Populations
- (2013) Nosratola D. Vaziri et al. BLOOD PURIFICATION
- Update on the long-term complications of renal transplantation
- (2013) Matthew J. Bottomley et al. BRITISH MEDICAL BULLETIN
- Mild Renal Dysfunction and Metabolites Tied to Low HDL Cholesterol Are Associated With Monocytosis and Atherosclerosis
- (2013) Anjali Ganda et al. CIRCULATION
- Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease
- (2013) Nosratola D. Vaziri Clinical and Experimental Nephrology
- Ezetimibe and bile acid sequestrants
- (2013) Patrick Couture et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
- (2013) Wanyin Hou et al. EUROPEAN HEART JOURNAL
- Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
- (2013) A. McConnachie et al. EUROPEAN HEART JOURNAL
- Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2
- (2013) Thimoteus Speer et al. IMMUNITY
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
- (2013) Kevin F. Erickson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia
- (2013) Christie M. Ballantyne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association between LDL-C and Risk of Myocardial Infarction in CKD
- (2013) M. Tonelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Randomized, Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients
- (2013) P. K. T. Li et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- LDL cholesterol in CKD—to treat or not to treat?
- (2013) Ziad A. Massy et al. KIDNEY INTERNATIONAL
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Summary of Recommendation Statements
- (2013) Kidney International Supplements
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ATP-citrate lyase: A mini-review
- (2012) Melanie Chypre et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Omega 3 Fatty Acids and Cardiovascular Outcomes
- (2012) Sradha Kotwal et al.
- Three Reasons to Abandon Low-Density Lipoprotein Targets
- (2012) Rodney A. Hayward et al.
- CKD, Plasma Lipids, and Common Carotid Intima-Media Thickness: Results from the Multi-Ethnic Study of Atherosclerosis
- (2012) J. A. Lamprea-Montealegre et al. Clinical Journal of the American Society of Nephrology
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Proprotein convertase subtilisin/kexin type 9 inhibition
- (2012) David A. Marais et al. CURRENT OPINION IN LIPIDOLOGY
- Arterial disease in chronic kidney disease
- (2012) William E Moody et al. HEART
- AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism
- (2012) Stephen L. Pinkosky et al. JOURNAL OF LIPID RESEARCH
- The PCSK9 decade
- (2012) Gilles Lambert et al. JOURNAL OF LIPID RESEARCH
- Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
- (2012) Suguru Yamamoto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Statins in the management of dyslipidemia associated with chronic kidney disease
- (2012) Murray Epstein et al. Nature Reviews Nephrology
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple functions of microsomal triglyceride transfer protein
- (2012) M Mahmood Hussain et al. Nutrition & Metabolism
- Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
- (2012) Hema Mistry et al. BMJ Open
- Clinical Guidelines, the Politics of Value, and the Practice of Medicine: Physicians at the Crossroads
- (2012) Richard A. Cooper et al. Journal of Oncology Practice
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
- (2011) R Peto BRITISH JOURNAL OF CANCER
- Kidney Function and Long-Term Medication Adherence after Myocardial Infarction in the Elderly
- (2011) T. I. Chang et al. Clinical Journal of the American Society of Nephrology
- Atorvastatin and Low-Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus Patients on Hemodialysis
- (2011) W. Marz et al. Clinical Journal of the American Society of Nephrology
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- New Insights Into Lipid Metabolism in Chronic Kidney Disease
- (2011) George A. Kaysen JOURNAL OF RENAL NUTRITION
- Prevention of cardiovascular disease in adult recipients of kidney transplants
- (2011) Alan G Jardine et al. LANCET
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- The ABC transporters in lipid flux and atherosclerosis
- (2011) Iryna Voloshyna et al. PROGRESS IN LIPID RESEARCH
- The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices
- (2010) Pedro Plans-Rubió American Journal of Cardiovascular Drugs
- Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk
- (2010) Paul M Ridker et al.
- Arterial stiffness in chronic kidney disease: causes and consequences
- (2010) C. D. Chue et al. HEART
- PCSK9R46L, Low-Density Lipoprotein Cholesterol Levels, and Risk of Ischemic Heart Disease
- (2010) Marianne Benn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein
- (2010) Paul M. Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients
- (2010) Maurizio Postorino et al. KIDNEY INTERNATIONAL
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients
- (2010) Kamal S. Hassan et al. RENAL FAILURE
- Reduction in Cardiovascular Death After Kidney Transplantation
- (2010) Helen Pilmore et al. TRANSPLANTATION
- Dyslipidemia in renal disease: Causes, consequences and treatment
- (2010) Joana Mesquita et al. Endocrinologia y Nutricion
- Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
- (2009) Irena Levitan et al. ANTIOXIDANTS & REDOX SIGNALING
- Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults
- (2009) Amanda K. Marma et al.
- Fibrate therapy and renal function
- (2009) Domenic A. Sica Current Atherosclerosis Reports
- Lowering Low-Density Lipoprotein Cholesterol: Statins, Ezetimibe, Bile Acid Sequestrants, and Combinations: Comparative Efficacy and Safety
- (2009) Runhua Hou et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Lipid re-screening: what is the best measure and interval?
- (2009) O. Takahashi et al. HEART
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
- (2009) Dinanda J. de Jager JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipid and Lipoprotein Metabolism in Chronic Kidney Disease
- (2009) George A. Kaysen JOURNAL OF RENAL NUTRITION
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Revascularization versus Medical Therapy for Renal-Artery Stenosis
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Causes of Dysregulation of Lipid Metabolism in Chronic Renal Failure
- (2009) Nosratola D. Vaziri SEMINARS IN DIALYSIS
- Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients
- (2008) B. L. Kasiske et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
- (2008) M J Forrest et al. BRITISH JOURNAL OF PHARMACOLOGY
- New approaches to target microsomal triglyceride transfer protein
- (2008) Mohammed Mahmood Hussain et al. CURRENT OPINION IN LIPIDOLOGY
- Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1)
- (2008) Dong Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Managing Dyslipidemia in Chronic Kidney Disease
- (2008) Charles R. Harper et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease
- (2008) James Shepherd et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
- (2008) M. Svensson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V
- (2008) S. Seiler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
- (2008) Frederick F Samaha et al. Nature clinical practice. Cardiovascular medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started